درباره این اپیزود
Stanford's Branimir Sikic discusses the importance of, and offers guidance to achieve the development of personalized medicines that are risk adapted genomic guided therapies which make a major impact on the disease. (September 15, 2008)
انگلیسی
ایالات متحده آمریکا
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
جستجوی اپیزودهای گذشته
اپیزودهای قبلی Comprehensive Cancer Research Training Program را جستجو کن.
قسمت های دیگر در این پادکست
Dr. Saul Rosenberg discusses the history of diagnosis and treatment of Hodgkin's Disease and the remarkable improvement in curability since the 1960's. (September 15, 2008)
Frank McCormick discusses how each protein is a problem in the use of pharmaceutics to combat cancer and suggests that developing a platform that can be used for anything is the process that will alter the future of cancer treatment. (September 16, 2008)
Anthony Oro, MD, PhD, discusses how Hedgehog signally is a model for a variety of morphogenetic signals, that taking stem cells to effect wound healing may have an important role in pathogenesis. (September 16, 2008)
Dr. Michael Cleary discusses this work on the role of chromosomal aberrations in causing cancer and its implications for cancer treatment. (September 18, 2008)
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Stanford University است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
